Published in BMJ on November 13, 2012
Comparisons between novel oral anticoagulants and vitamin K antagonists in patients with CKD. J Am Soc Nephrol (2014) 1.57
Clinical trials registries are under-utilized in the conduct of systematic reviews: a cross-sectional analysis. Syst Rev (2014) 1.06
Dabigatran etexilate and risk of myocardial infarction, other cardiovascular events, major bleeding, and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc (2014) 1.00
Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison. Br J Clin Pharmacol (2014) 0.89
New oral anticoagulants: discussion on monitoring and adherence should start now! Thromb J (2013) 0.88
Recent meta-analyses neglect previous systematic reviews and meta-analyses about the same topic: a systematic examination. BMC Med (2015) 0.84
Alternative to oral dicoumarin anticoagulants: Considerations in dental care. J Clin Exp Dent (2013) 0.82
Risk of bleeding during long-term anticoagulation with warfarin: a tertiary care center experience. Blood Coagul Fibrinolysis (2015) 0.78
Reversal of target-specific oral anticoagulants. Drug Discov Today (2014) 0.78
Measurement of rivaroxaban and apixaban in serum samples of patients. Eur J Clin Invest (2014) 0.78
Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism. Int J Emerg Med (2013) 0.78
A rapid pro-hemostatic approach to overcome direct oral anticoagulants. Nat Med (2016) 0.77
Long term Anticoagulation at Crossroads. Maedica (Buchar) (2013) 0.75
How we treat bleeding associated with direct oral anticoagulants. Blood Transfus (2016) 0.75
Bleeding complications from the direct oral anticoagulants. BMC Hematol (2015) 0.75
Risk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies. Drug Saf (2016) 0.75
Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials. Eur J Epidemiol (2016) 0.75
Almanac 2013: novel non-coronary cardiac interventions. Wien Klin Wochenschr (2013) 0.75
Non-Vitamin K Oral Anticoagulants (NOACs) and Their Reversal. Curr Neurol Neurosci Rep (2017) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med (2012) 11.86
Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med (2010) 9.92
Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med (2009) 9.17
Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med (2011) 7.30
Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials. Arch Intern Med (2012) 5.56
Indirect comparisons of competing interventions. Health Technol Assess (2005) 4.33
Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation. Am J Cardiol (2012) 2.76
Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants. J Thromb Haemost (2007) 2.72
Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial. JAMA (2005) 1.87
Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study. J Thromb Haemost (2008) 1.55
Lessons from and cautions about noninferiority and equivalence randomized trials. JAMA (2006) 1.40
Dabigatran and rivaroxaban for prevention of venous thromboembolism--systematic review and adjusted indirect comparison. J Clin Pharm Ther (2011) 1.01
New oral anticoagulants: a view from the laboratory. Am J Hematol (2012) 0.90
A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I. J Thromb Haemost (2003) 0.87
Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol (2009) 12.05
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.55
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.12
Clinical classification of pulmonary hypertension. J Am Coll Cardiol (2004) 5.87
Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med (2013) 5.60
The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol (2010) 5.54
Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med (2009) 5.48
Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol (2010) 4.53
Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis. Circulation (2014) 3.78
Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect? Ann Intern Med (2004) 3.62
A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet (2004) 3.52
Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis. J Am Coll Cardiol (2008) 3.43
Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med (2013) 3.40
Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med (2010) 3.06
Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation. Circulation (2012) 2.96
Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation. Am J Cardiol (2012) 2.76
Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials. J Am Coll Cardiol (2005) 2.75
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2008) 2.67
Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med (2003) 2.64
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol (2006) 2.42
Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis. J Am Coll Cardiol (2013) 2.29
Adjunctive thrombectomy for acute myocardial infarction: A bayesian meta-analysis. Circ Cardiovasc Interv (2010) 2.27
Role of frailty in patients with cardiovascular disease. Am J Cardiol (2009) 2.19
Preoperative anxiety as a predictor of mortality and major morbidity in patients aged >70 years undergoing cardiac surgery. Am J Cardiol (2013) 2.18
The cardiovascular effects of peroxisome proliferator-activated receptor agonists. Am J Med (2012) 2.15
Evaluation of outcomes in chronic venous disorders of the leg: development of a scientifically rigorous, patient-reported measure of symptoms and quality of life. J Vasc Surg (2003) 2.10
Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial. Ann Intern Med (2013) 2.09
Alternative smoking cessation aids: a meta-analysis of randomized controlled trials. Am J Med (2012) 2.06
Off-pump vs. on-pump coronary artery bypass surgery: an updated meta-analysis and meta-regression of randomized trials. Eur Heart J (2011) 1.96
Coronary artery disease in the developing world. Am Heart J (2004) 1.95
Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation. Arch Intern Med (2012) 1.94
Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction. Arch Intern Med (2005) 1.91
Meta-analysis of ten trials on the effectiveness of the radial versus the femoral approach in primary percutaneous coronary intervention. Am J Cardiol (2011) 1.91
Agricultural subsidies and the American obesity epidemic. Am J Prev Med (2013) 1.83
Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J (2011) 1.82
Thrombophilic disorders and fetal loss: a meta-analysis. Lancet (2003) 1.81
A comparison of brand-name drug prices between Canadian-based Internet pharmacies and major U.S. drug chain pharmacies. Ann Intern Med (2005) 1.80
Investigating socio-economic disparities in preterm birth: evidence for selective study participation and selection bias. Paediatr Perinat Epidemiol (2009) 1.75
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease. Ann Rheum Dis (2007) 1.72
The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost (2005) 1.72
Stress pathways to spontaneous preterm birth: the role of stressors, psychological distress, and stress hormones. Am J Epidemiol (2009) 1.72
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ (2008) 1.71
Meta-analysis of usefulness of d-dimer to diagnose acute aortic dissection. Am J Cardiol (2011) 1.70
Sex-related differences in access to care among patients with premature acute coronary syndrome. CMAJ (2014) 1.67
The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation (2014) 1.64
High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. Eur Respir J (2012) 1.62
Safety of laparoscopic vs open bariatric surgery: a systematic review and meta-analysis. Arch Surg (2011) 1.58
Use of warfarin and risk of urogenital cancer: a population-based, nested case-control study. Lancet Oncol (2007) 1.57
Effects of early and late administration of angiotensin-converting enzyme inhibitors on mortality after myocardial infarction. Am J Med (2003) 1.54
The occurrence of venous thromboembolism in cancer patients following major surgery. Thromb Res (2012) 1.53
Class effects of statins in elderly patients with congestive heart failure: a population-based analysis. Am Heart J (2007) 1.53
Meta-analysis of rivaroxaban and bleeding risk. Am J Cardiol (2013) 1.53
Myocardial laser revascularization for the treatment of end-stage coronary artery disease. J Am Coll Cardiol (2003) 1.53
Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS). A randomized controlled trial. Thromb Haemost (2008) 1.50
Symptomatic Brugada unmasked by fever. Isr Med Assoc J (2008) 1.49
Effectiveness and safety of drug-eluting stents in vein grafts: a meta-analysis. Am Heart J (2010) 1.47
Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study. Thromb Haemost (2013) 1.47
Long-term risk of ischemic stroke associated with rofecoxib. Cardiovasc Drugs Ther (2007) 1.46
In-hospital management of atrial fibrillation: the CHADS₂ score predicts increased cost. Can J Cardiol (2011) 1.46
Sex differences in acute coronary syndrome symptom presentation in young patients. JAMA Intern Med (2013) 1.45
Application of the Seattle heart failure model in patients >80 years of age enrolled in a tertiary care heart failure clinic. Am J Cardiol (2012) 1.43
Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect. CMAJ (2005) 1.43
Pulmonary arterial hypertension: pathophysiology and anesthetic approach. Anesthesiology (2003) 1.42
Hemodynamic stability after transitioning between endothelin receptor antagonists in patients with pulmonary arterial hypertension. Can J Cardiol (2012) 1.42
Acute vasodilator responsiveness and microvascular recruitment in idiopathic pulmonary arterial hypertension. Ann Intern Med (2015) 1.42
Addition of frailty and disability to cardiac surgery risk scores identifies elderly patients at high risk of mortality or major morbidity. Circ Cardiovasc Qual Outcomes (2012) 1.41
Comparing invasive and noninvasive management strategies for acute myocardial infarction using administrative databases. Am Heart J (2008) 1.40
Lack of benefit for routine functional testing early after coronary artery bypass graft surgery: results from the ROSETTA-CABG Registry. J Invasive Cardiol (2006) 1.40
The post-thrombotic syndrome after upper extremity deep venous thrombosis in adults: a systematic review. Thromb Res (2005) 1.27
Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study. CMAJ (2006) 1.27
Post-thrombotic syndrome: prevalence, prognostication and need for progress. Br J Haematol (2009) 1.27
Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med (2013) 1.22
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol (2008) 1.21
Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol (2011) 1.21
Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials. Eur Heart J (2008) 1.20
Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. Am Heart J (2003) 1.20
Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Haematologica (2010) 1.20
In-hospital cost of total hip arthroplasty in Canada and the United States. J Bone Joint Surg Am (2004) 1.19
Anemia and mortality in acute coronary syndromes: a systematic review and meta-analysis. Am Heart J (2012) 1.17
Isolated aerobic exercise and weight loss: a systematic review and meta-analysis of randomized controlled trials. Am J Med (2011) 1.16
The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. Am J Med (2002) 1.15
Mid-trimester maternal plasma cytokines and CRP as predictors of spontaneous preterm birth. Cytokine (2009) 1.15
Acute coronary syndrome associated with myocardial bridging due to ergotamine treatment for migraine. Int J Cardiol (2006) 1.14
Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review. Am J Med (2009) 1.11
Beneficial effects of right ventricular non-apical vs. apical pacing: a systematic review and meta-analysis of randomized-controlled trials. Europace (2011) 1.11